Results 61 to 70 of about 674 (175)
, 2016 \ua9 2016 Elsevier Ltd. All rights reserved.Toxicity related to drug misuse is a common reason for hospital presentation. The recent emergence of substantial numbers of novel psychoactive substances has made management more challenging because the exact ...
Thomas SHL, Hill SL
core
Novel Ergoline Compounds as 5-HT2A Agonists for Treating Mood Disorders Such as Depressive Disorders and Bipolar Disorders. [PDF]
ACS Med Chem LettSabnis RW.
europepmc +1 more source
, 1983 Part I. Genetics and Ergoline Alkaloid Formation in Penicillium roquefortii Thom. For the genetic investigation of the formation of ergot alkaloids, organisms other than Claviceps could be considered.
HONG, SOOBOK LEE
core
Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics. [PDF]
Front PsychiatryWilliams ML +3 more
europepmc +1 more source
The renaissance of research on psychedelics in child and adolescent psychopharmacology. [PDF]
Child Adolesc Psychiatry Ment HealthCrocq MA, Auby P.
europepmc +1 more source
, 1982 Experiments were conducted in pentobarbital-anesthetized dogs to examine the cardiovascular actions of the dopaminergic ergolines lergotrile and pergolide.
Barrett, Richard J.
core
The structural diversity of psychedelic drug actions revealed. [PDF]
Nat CommunGumpper RH +13 more
europepmc +1 more source
Molecular and Medical Aspects of Psychedelics. [PDF]
Int J Mol Sci, 2023 Wojtas A, Gołembiowska K.
europepmc +1 more source
Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. [PDF]
Pharmacol Res PerspectKazdan J, Ladha KS, Husain MI.
europepmc +1 more source